Akebia Announced Positive Top-Line Results from Global Phase 3 Program of Vadadustat for Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients on Dialysis; Reports First Quarter 2020 Fin

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/17/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. TLT
7. LEN
8. APO
9. ON
10. AWK

Go back to Akebia Announced Positive Top-Line Results from Global Phase 3 Program of Vadadustat for Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients on Dialysis; Reports First Quarter 2020 Fin
AKEBIA THERAPEUTICS (NASDAQ: AKBA) Delayed: 0.92 --0 (-0%)
Previous Close $0.92    52 Week High $13.20 
Open $0.92    52 Week Low $7.00 
Day High $0.92    P/E N/A 
Day Low $0.92    EPS $0.00 
Volume 75       

Mitsubishi Chemical Holdings Corp Unsponsored ADR (AMEX: MTLHY) Delayed: 37.05 --0 (-0%)
Previous Close $37.05    52 Week High $34.07 
Open $37.05    52 Week Low $21.84 
Day High $37.05    P/E N/A 
Day Low $37.05    EPS $0.00 
Volume 6,623       

Mitsubishi Tanabe Pharma Corporation Sponsored ADR (AMEX: MTZPY) Delayed: 18.60 --0 (-0%)
Previous Close $18.60    52 Week High $21.90 
Open $0.13    52 Week Low $15.98 
Day High $18.60    P/E N/A 
Day Low $18.60    EPS $0.00 
Volume 5,773